Gattaz WF - Search Results

1

Olanzapine versus flupenthixol in the treatment of inpatients with schizophrenia: a randomized double-blind trial.

Gattaz WF, Diehl A, Geuppert MS, Hubrich P, Schmitt A, Linde I, Maras A, Dittmann RW. Gattaz WF, et al. Pharmacopsychiatry. 2004 Nov;37(6):279-85. doi: 10.1055/s-2004-832684. Pharmacopsychiatry. 2004. PMID: 15551194 Clinical Trial.

2

Differential effects of trimipramine and fluoxetine on sleep in geriatric depression.

Wolf R, Dykierek P, Gattaz WF, Maras A, Kohnen R, Dittmann RW, Geuppert M, Riemann D, Berger M. Wolf R, et al. Among authors: gattaz wf. Pharmacopsychiatry. 2001 Mar;34(2):60-5. doi: 10.1055/s-2001-15183. Pharmacopsychiatry. 2001. PMID: 11302565 Clinical Trial.

3

Fluoxetine versus trimipramine in the treatment of depression in geriatric patients.

Wehmeier PM, Kluge M, Maras A, Riemann D, Berger M, Kohnen R, Dittmann RW, Gattaz WF. Wehmeier PM, et al. Among authors: gattaz wf. Pharmacopsychiatry. 2005 Jan;38(1):13-6. doi: 10.1055/s-2005-837765. Pharmacopsychiatry. 2005. PMID: 15706460 Clinical Trial.

4

Increased brain membrane fluidity in schizophrenia.

Eckert GP, Schaeffer EL, Schmitt A, Maras A, Gattaz WF. Eckert GP, et al. Among authors: gattaz wf. Pharmacopsychiatry. 2011 Jun;44(4):161-2. doi: 10.1055/s-0031-1279731. Epub 2011 Jun 27. Pharmacopsychiatry. 2011. PMID: 21710408

5

[Antipsychotics and phospholipid metabolism in schizophrenia].

Schmitt A, Maras A, Braus DF, Petroianu G, Jatzko A, Gattaz WF. Schmitt A, et al. Among authors: gattaz wf. Fortschr Neurol Psychiatr. 2001 Nov;69(11):503-9. doi: 10.1055/s-2001-18379. Fortschr Neurol Psychiatr. 2001. PMID: 11704897 German.

6

Effects of antipsychotic treatment on membrane phospholipid metabolism in schizophrenia.

Schmitt A, Maras A, Petroianu G, Braus DF, Scheuer L, Gattaz WF. Schmitt A, et al. Among authors: gattaz wf. J Neural Transm (Vienna). 2001;108(8-9):1081-91. doi: 10.1007/s007020170026. J Neural Transm (Vienna). 2001. PMID: 11716143

7

Does the degree of smoking effect the severity of tardive dyskinesia? A longitudinal clinical trial.

Diehl A, Reinhard I, Schmitt A, Mann K, Gattaz WF. Diehl A, et al. Among authors: gattaz wf. Eur Psychiatry. 2009 Jan;24(1):33-40. doi: 10.1016/j.eurpsy.2008.07.007. Epub 2008 Sep 6. Eur Psychiatry. 2009. PMID: 18774276

8

Body mass index increase, serum leptin, adiponectin, neuropeptide Y and lipid levels during treatment with olanzapine and haloperidol.

Raposo NR, Ferreira AS, Gattaz WF. Raposo NR, et al. Among authors: gattaz wf. Pharmacopsychiatry. 2011 Jul;44(5):169-72. doi: 10.1055/s-0031-1280793. Epub 2011 Jul 5. Pharmacopsychiatry. 2011. PMID: 21732272 Clinical Trial.

9

Increased platelet phospholipase A2 activity in schizophrenia.

Gattaz WF, Schmitt A, Maras A. Gattaz WF, et al. Schizophr Res. 1995 Jul;16(1):1-6. doi: 10.1016/0920-9964(94)00060-l. Schizophr Res. 1995. PMID: 7547640

10

Conjugated estrogens as adjuvant therapy in the treatment of acute schizophrenia: a double-blind study.

Louzã MR, Marques AP, Elkis H, Bassitt D, Diegoli M, Gattaz WF. Louzã MR, et al. Among authors: gattaz wf. Schizophr Res. 2004 Feb 1;66(2-3):97-100. doi: 10.1016/S0920-9964(03)00082-3. Schizophr Res. 2004. PMID: 15061241 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

380 results

Search Page

Filters